Pro-Link® Stand-Alone Cervical Spacer System

K160066 · Life Spine, Inc. · OVE · Sep 2, 2016 · Orthopedic

Device Facts

• Record ID: K160066
• Device Name: Pro-Link® Stand-Alone Cervical Spacer System
• Applicant: Life Spine, Inc.
• Product Code: OVE · Orthopedic
• Decision Date: Sep 2, 2016
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 888.3080
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The Pro-Link® Stand-Alone Cervical Spacer System is intended to be used with the screws provided and requires no additional supplementary fixation. The Pro-Link® Stand-Alone Cervical Spacer System is intended for spinal fusion procedures in skeletally mature patients with degenerative disc disease (DDD) at one disc level (C2-T1). DDD is defined as discogenic pain with degeneration of the disc confirmed by history and radiographic studies. It is to be used in patients who have had at least six weeks of nonoperative treatment. This device is intended to be used with autogenous bone graft.

Device Story

Intervertebral body fusion device; used in cervical spine (C2-T1) for fusion procedures. Implant fabricated from Titanium (Ti 6Al-4V ELI) or PEEK-OPTIMA LT1; includes tantalum markers and titanium pins. Hollow design allows packing with autogenous bone graft to promote fusion. Superior/inferior surfaces feature teeth to interface with vertebral endplates; prevents rotation/migration. System includes titanium bone screws for internal fixation and a central threaded hole for a titanium lock plate to prevent screw back-out. Used by surgeons in clinical settings. Provides structural support and stabilization during fusion; benefits patients by addressing discogenic pain associated with DDD.

Clinical Evidence

Bench testing only. Mechanical testing including compression and torsion was conducted in accordance with the FDA guidance document 'Intervertebral Fusion Device' (June 12, 2009) to demonstrate substantial equivalence.

Technological Characteristics

Materials: Titanium (Ti 6Al-4V ELI) or PEEK-OPTIMA LT1; tantalum markers; titanium pins. Design: Hollow intervertebral spacer with teeth on superior/inferior surfaces; includes titanium bone screws and a titanium lock plate. Connectivity: None. Energy source: None. Sterilization: Not specified.

Indications for Use

Indicated for spinal fusion in skeletally mature patients with degenerative disc disease (DDD) at one level (C2-T1) confirmed by history and radiographic studies, following at least six weeks of nonoperative treatment.

Regulatory Classification

Identification

An intervertebral body fusion device is an implanted single or multiple component spinal device made from a variety of materials, including titanium and polymers. The device is inserted into the intervertebral body space of the cervical or lumbosacral spine, and is intended for intervertebral body fusion.

Special Controls

*Classification.* (1) Class II (special controls) for intervertebral body fusion devices that contain bone grafting material. The special control is the FDA guidance document entitled “Class II Special Controls Guidance Document: Intervertebral Body Fusion Device.” See § 888.1(e) for the availability of this guidance document.(2) Class III (premarket approval) for intervertebral body fusion devices that include any therapeutic biologic (e.g., bone morphogenic protein). Intervertebral body fusion devices that contain any therapeutic biologic require premarket approval. (c) *Date premarket approval application (PMA) or notice of product development protocol (PDP) is required.* Devices described in paragraph (b)(2) of this section shall have an approved PMA or a declared completed PDP in effect before being placed in commercial distribution.

Predicate Devices

• Pro-Link Cervical Spacer System (K121151)
• Endoskeleton® TCS Interbody Fusion Device (K151596)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the seal for the Department of Health & Human Services - USA. The seal is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the seal is an abstract image of a human face.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

September 2, 2016

Life Spine, Incorporated Randy Lewis General Manager 13951 South Quality Drive Huntley, Illinois 60142

Re: K160066

Trade/Device Name: Pro-link® Stand-Alone Cervical Spacer System Regulation Number: 21 CFR 888.3080 Regulation Name: Intervertebral body fusion device Regulatory Class: Class II Product Code: OVE Dated: August 5, 2016 Received: August 8, 2016

Dear Mr. Lewis:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set

{1}------------------------------------------------

forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely,

# Mark N. Melkerson -S

Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

# Indications for Use

510(k) Number (if known) K160066

Device Name

Pro-Link® Stand-Alone Cervical Spacer System

Indications for Use (Describe)

The Pro-Link® Stand-Alone Cervical Spacer System is intended to be used with the screws provided and requires no additional supplementary fixation.

The Pro-Link® Stand-Alone Cervical Spacer System is intended for spinal fusion procedures in skeletally mature patients with degenerative disc disease (DDD) at one disc level (C2-T1). DDD is defined as discogenic pain with degeneration of the disc confirmed by history and radiographic studies. It is to be used in patients who have had at least six weeks of nonoperative treatment. This device is intended to be used with autogenous bone graft.

X Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

#### CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

## 510(k) Summary Pro-Link® Stand-Alone Cervical Spacer System

| Submitted By: | Life Spine, Inc.<br>13951 S. Quality Drive<br>Huntley, IL 60142<br>Telephone: [phone]<br>Fax: [phone] |
|-----------------------|--------------------------------------------------------------------------------------------------------------------------------|
| 510(k) Contact: | Randy Lewis<br>Life Spine, Inc.<br>13951 S. Quality Drive<br>Huntley, IL 60142<br>Telephone: [phone]<br>Fax: [phone] |
| Date Prepared: | August 15th, 2016 |
| Trade Name: | Pro-Link® Stand-Alone Cervical Spacer System |
| Common Name: | Intervertebral Body Fusion Device |
| Classification: | OVE, 21 CFR 888.3080, Class II |
| Primary Predicate : | Pro-Link Cervical Spacer System (K121151) |
| Additional Predicate: | Endoskeleton® TCS Interbody Fusion Device (K151596) |

### Device Description:

The Pro-Link® Stand-Alone Cervical Spacer System is intended to serve as an intervertebral body fusion device. The implant is available in a range of sizes and footprints to suit the individual pathology and anatomical conditions of the patient. It is fabricated and manufactured from either Titanium (Ti 6Al-4V ELI) or Polyetheretherketone (PEEK-OPTIMA LT1) with tantalum markers and titanium pins (Ti 6Al-4V ELI). The implant is hollow to permit packing with autogenous bone graft to help promote intervertebral body fusion. The superior and inferior surfaces have teeth to assist in the interface with the vertebral endplates to prevent rotation and/or migration. The implant has two pockets to permit placement of titanium bone screws (Ti 6Al-4V ELI) through the interbody to provide internal fixation. The implant also has one central threaded hole to permit the insertion of a titanium lock plate (Ti 6Al-4V ELI) to prevent screw back out.

{4}------------------------------------------------

Cmlo r repul'ctg"lyngpf gf "htt'ukpi ng"wys" post" bqvdg"tgwugf "wpf gt"cp {" ekewo uxpegulDo not use any of the Pro-Link® Stand-Alone Cervical Spacer System components with components from any other system or manufacturer. The Pro-Link® Stand-Alone Cervical Spacer System components should never be reused under any circumstances.

## Intended Use of the Device<

Vj g'Rtq/Npm "Ucpf /Cmpg'Egtxlecn'Ur cegt 'U{ urgo "ku"kygpf gf "vq"dg"wugf" y kij "ij g"letgy u" r tqxkf gf "cpf "tgs wkgu"pq"cf f kkqpcn"uwr r ngo gpvct { "hkccvqp0"

Vi g"Rta/Nom "Ucpf /Crape"Egtxlecn"Ur cegt"U/ urgo "ki"lovepf gf "htt"ur lochlwukgp"r tgegf w.gu" lp"ungrgicm" "o cwtg"r cylgpw"y kj "f gi gpgtcckxg"f ke"f kigcug"f kxe"rgxgd"tE4/V3+0" F F F "W" ghogf "cu"f kreai goke"r ckp"y ki "f gi gpgt cvap"ah" i g"f kxe"eaphtto gf "d { "[ krat { "cpt " tcf kqi tcr j le'uwf kgu0"K'ku'vq''dg''vugf 'lp''r cxg'' cf ''cv'rgcuvukz''y ggml'al'pqp/ qr gtc wxg\'tgc o gp\0"Vj ki'f gxleg"!u"ky\gpf gf "q"dg"wugf "y kj "cwqi gpqwu"dqpg" tch(0"

11

## Technological Characteristics:

Vj g'Rtq/Npm "Uxpf /Cmpg"Egtxkecn"Ur cegt"Uj urgo "lu"uwducpvkcm} "gs wkxcrgpv"q"vj g" r t gf lecvg'u{ ungo u'lp' gt o u'qh'f guli p. ''o cygtlem." 'lof lectlypu'hqt 'wug'c of 'luk loi 0'

## Performance Data:

Hoke"greo gpy"cpcn uku."gpi loggtkoi "tckgpcrg"cpf "eqphto cvgt/"> gej cplecn"guyoi "an'uc" eqo r tgulqp"cpf "ucve":qtulqp"eqpf weyf "k":ceeatf cpeg"y kj "5Ercui"KUr gelcriEqpytqm"| wM cpeg" F qewo gpv "føvgtx.gtvgdt.cn"Hwalqp"F gxlegö."Lypg"34. "4229. "y cu"r tgugpyef "va" go qputcve" vj cv'pg' 'y qtuvecug'eqpf kkqp'y cu'llow qf wegf '\q''\j g'Rtq/Nom "Uxpf /Crqpg"EgtxlectiUr cegt'' U{uygo 0""

" "

## Conclusion:

Vj g'Rtq/Npm "Ucpf/Crqpg"Egtxlecn"Ur cegt "U{ urgo "y cu"uj qy p"vq"dg"unduxcpvcm{ "gs vkxcrgpv" iq"ij g"rtgf lectg":"gxlegu"!p"} } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } r gth to cpeg()"